Neurol. praxi. 2014;15(4):213-215

Late manifestation of Pompe disease

MUDr. Tomáš Kalous
Centrum pro nervosvalová onemocnění, Neurologická klinika 1. LF UK a VFN, Praha

Pompe disease is an autosomal recessive hereditary storage disease caused by mutations in the gene for acid maltase leading to a varying degree of its deficiency, which causes accumulation of glycogen in all organs, especially in striated muscles and in newborns even in the myocardium. It is divided into two basic forms – the infantile and adult. In this article is presented a case report of adult-onset disease with the development of symptoms at the end of the 6th decade of age manifested gradually and progresses to asymmetric girdle weakness of the lower limbs. Due to very low occurrence of the disease and the absence of specific symptoms, usually the correct diagnosis is often complicated and lengthy. As a very simple and reliable test to detect the Pompe disease the dried blood spot test is used. The enzyme replacement therapy has been used as a treatment since 2006.

Keywords: Pompe disease, limb girdle weakness, myopathy, respiratory insufficiency

Published: September 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalous T. Late manifestation of Pompe disease. Neurol. praxi. 2014;15(4):213-215.
Download citation

References

  1. Baethmann M, Straub V, Reuser AJJ, Bodamer OA, Dohna-Schwake Ch, Eagle M, Evangelista T, Kroos MA, Mayhew A, Mellies U, van der Ploeg AT, Raben N, Schaller T. Pompe Disease 2nd edition. Bremen: UNI-MED, 2014.
  2. Bednařík J, Ambler Z, Růžička E, Bauer J, Cerman J, Česák T, Ehler E, Eliáš P, Havrdová E, Herman E, Hobza V, Hovorka J, Kadaňka Z, Komárek V, Kuba R, Látr I, Mareš J, Marková J, Marusič P, Mechl M, Náhlovský J, Němeček S, Němečková J, Nevšímalová S, Pícha D, Smrčka M, Šťourač P, Urban P, Voháňka S, Vymazal J. Klinická neurologie. Praha: Triton, 2010.
  3. Bednařík J, Gaillyová R, Kadaňka Z, Lukáš Z, Mechl M, Voháňka S, Vytopil M. Nemoci kosterního svalstva. Praha: Triton, 2001.
  4. Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, Annane D, Carlier PG, Orlikowski D. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Elsevier, Neuromuscular Disorders 21 (2011) 791-799. Go to original source... Go to PubMed...
  5. Ehler E, Malinová V, Linhart A, Dostálová G, Goláň L, Ješina P, Kraus J. Vzácná onemocnění. Olomouc: Solen, 2013.
  6. Malinová V. Glykogenóza II. typu (GSD II, m. Pompe). Současné možnosti diagnostiky a terapie). Klinická kazuistika. Neurol. praxi 2010; 11(5): 331-335.
  7. Ošlejšková H, Rusnáková Š, Voháňka S, Slouková E. Pompeho choroba v České republice - projekt screeningového vyšetření krve u rizikových pacientů pomocí, ,suché krevní kapky". Neurol. praxi 2009; 10(2): 102-106.
  8. Slouková E, Ošlejšková H, Voháňka S, Ješina P. Pompeho choroba. Neurol. praxi 2009; 10(3): 156-158.
  9. Špalek P. Pompeho choroba - patogenéza, klinický obraz, diagnostika a enzymatická substitučná liečba. Neurol. praxi 2009; 10(1): 44-48.
  10. Voháňka S. Zvýšená hladina kreatinkinázy. Interní Med. 2012; 14(8 a 9): 322-326.
  11. Zámečník J, Dahmen RA. Autofagické vakuolární myopatie - aneb Co nás neučila diferenciální diagnostika vakuol ve svalové biopsii. Cesk Patol 2013; 49(1): 39-45. Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.